Skip to main content
    S

    Senti Biosciences Inc (SNTI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.14
    -0.00 (-2.86%)

    Market Cap: $5.38M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Senti Biosciences Inc (SNTI) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Senti Biosciences are Neurosense Therapeutics (NRSN), Ensysce Biosciences (ENSC) and Soligenix (SNGX). By market cap, Senti Biosciences ranks 8th of the 13 companies on this page; Quantum BioPharma (QNTM) is the largest at $10.35M.

    Peer Comparison

    SNTI's ROIC of 1039.8% is above the peer median of -205.3%, and its revenue growth of -100.0% is below the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Senti Biosciences (SNTI)$5.38MN/A57.2x0.0%1039.8%-100.0%0.00%
    Neurosense Therapeutics Ltd (NRSN)$3.21MN/AN/A0.0%N/A0.0%0.00%
    Ensysce Biosciences Inc (ENSC)$8.14MN/A1.2x-280.5%-260.6%-15.1%0.00%
    Soligenix Inc. (SNGX)$7.50MN/AN/A0.0%N/A-100.0%0.00%
    Quantum BioPharma Ltd. (QNTM)$10.35MN/AN/A0.0%-150.1%0.0%0.00%
    CNS Pharmaceuticals Inc (CNSP)$4.22MN/AN/A0.0%N/A0.0%0.00%
    Tempest Therapeutics Inc (TPST)$7.64MN/AN/A0.0%-783.6%0.0%0.00%
    Exicure Inc (XCUR)$7.07MN/AN/A0.0%N/A928.0%0.00%
    GT Biopharma Inc (GTBP)$7.67MN/AN/A0.0%N/A0.0%0.00%
    FibroBiologics, Inc. Common Stock (FBLG)$6.57MN/AN/A0.0%N/A0.0%0.00%
    Imunon Inc (IMNN)$4.08MN/AN/A0.0%-131.5%0.0%0.00%
    GRI Bio Inc. (GRI)$3.72MN/AN/A0.0%N/A0.0%0.00%
    Xenetic Biosciences Inc (XBIO)$3.89MN/A1.2x-75.9%N/A12.0%0.00%
    Peer median$6.82MN/A1.2x0.0%-205.3%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Senti Biosciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Neurosense Therapeutics Ltd (NRSN)
    Neurosense Therapeutics Ltd (NRSN) is a clinical-stage biotechnology firm dedicated to innovating treatments for neurodegenerative diseases...
    Ensysce Biosciences Inc (ENSC)
    Ensysce Biosciences, Inc., a clinical-stage biotechnology company, is dedicated to the development of various prescription drugs.
    ENSC competitors
    Soligenix Inc. (SNGX)
    Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States.
    SNGX competitors
    Quantum BioPharma Ltd. (QNTM)
    Quantum BioPharma Ltd. (QNTM) is an innovative biotechnology company focused on advancing transformative therapies for oncology and autoimmune diseases.
    QNTM competitors
    CNS Pharmaceuticals Inc (CNSP)
    CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central...
    CNSP competitors
    Tempest Therapeutics Inc (TPST)
    Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated...
    TPST competitors
    Exicure Inc (XCUR)
    Exicure, Inc., a clinical-stage biotechnology company, develops therapies for neurology, immuno-oncology, inflammatory diseases...
    XCUR competitors
    GT Biopharma Inc (GTBP)
    GT Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its...
    GTBP competitors
    FibroBiologics, Inc. Common Stock (FBLG)
    FibroBiologics, Inc. is an innovative biotechnology company dedicated to advancing regenerative medicine through its proprietary fibroblast cell technology...
    FBLG competitors
    Imunon Inc (IMNN)
    Imunon Inc. is a clinical-stage biotechnology company at the forefront of developing innovative immune-mediated therapies targeting cancer and infectious...
    IMNN competitors
    GRI Bio Inc. (GRI)
    GRI Bio Inc. is an innovative biotechnology company focused on leveraging microbiome technology to develop cutting-edge therapeutics in immunology and oncology.
    GRI competitors
    Xenetic Biosciences Inc (XBIO)
    Xenetic Biosciences, Inc., a biopharmaceutical company, is focused on advancing XCART...
    XBIO competitors

    Frequently Asked Questions About SNTI

    Who are Senti Biosciences' main competitors?

    The companies most similar to Senti Biosciences include Neurosense Therapeutics (NRSN), Ensysce Biosciences (ENSC), Soligenix (SNGX), Quantum BioPharma (QNTM) and CNS Pharmaceuticals (CNSP), listed from the closest match.

    Who is Senti Biosciences' biggest competitor?

    Quantum BioPharma (QNTM) is the largest of the similar companies at $10.35M; Neurosense Therapeutics (NRSN) is the closest match by business profile, size, sector and industry.

    How does SNTI stock compare with its competitors?

    SNTI's P/S is 57.2x against a peer median of 1.2x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Senti Biosciences' competitors pays a higher dividend?

    Senti Biosciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Senti Biosciences bigger than its competitors?

    No. Senti Biosciences is 8th by market cap among the 13 companies on this page; the largest is Quantum BioPharma (QNTM) at $10.35M.